Your browser doesn't support javascript.
loading
[Rituximab for treatment of Felty's syndrome]. / Rituximab zur Therapie des Felty-Syndroms.
Z Rheumatol ; 73(5): 465-6, 468, 2014 Jun.
Article in De | MEDLINE | ID: mdl-24659095
ABSTRACT
Felty's syndrome is a rare variant of severe seropositive rheumatoid arthritis with neutropenia and splenomegaly. It is difficult to treat and associated with a poor prognosis due to the substantial risk of infections. This article presents the case of a patient with refractory disease who responded to rituximab with permanent normalization of neutrophil counts. Repeated infusions were necessary to induce and maintain remission.
Subject(s)
Search on Google
Collection: 01-internacional Database: MEDLINE Main subject: Splenomegaly / Felty Syndrome / Antibodies, Monoclonal, Murine-Derived / Neutropenia Type of study: Prognostic_studies Limits: Aged / Humans / Male Language: De Journal: Z Rheumatol Year: 2014 Document type: Article
Search on Google
Collection: 01-internacional Database: MEDLINE Main subject: Splenomegaly / Felty Syndrome / Antibodies, Monoclonal, Murine-Derived / Neutropenia Type of study: Prognostic_studies Limits: Aged / Humans / Male Language: De Journal: Z Rheumatol Year: 2014 Document type: Article